CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Grant or award Chief Technology Officer acquired 96,213 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 123,064 shares (grant or award)
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Regulation FD disclosure
- S-3 Offering Registration Statement
- 4 Derivatives Options or other derivatives
Page 18 of 28 · 547 filings